Tansey Casey M's Form 4 filing
Carlsmed, Inc. (CARL) · filed Jul 24, 2025
- Accession no.
- 0001415889-25-020276
- Filed
- Jul 24, 2025, 8:47 PM ET
- Trade date
- Jul 24, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions and 7 derivative transactions. It was filed on the trade date.
This filing was later replaced by the amendment 0001193125-26-392111 (Sep 15, 2026). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tansey Casey MCIK 0001474322 | 10% Owner |
| U.S. Venture Partners XII, L.P.CIK 0001734819 | 10% Owner |
| Presidio Management Group XII, L.L.C.CIK 0001734820 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 24, 2025 | Common Stock | CConversionAcquired | +2,948,794 | –F1 | – | 2,948,794 | Indirect | |
| Jul 24, 2025 | Common Stock | CConversionAcquired | +825,135 | –F1 | – | 3,773,929 | Indirect | |
| Jul 24, 2025 | Common Stock | CConversionAcquired | +531,877 | –F1 | – | 4,305,806 | Indirect | |
| Jul 24, 2025 | Common Stock | CConversionAcquired | +149,655 | –F1 | – | 149,655 | Indirect | |
| Jul 24, 2025 | Common Stock | CConversionAcquired | +41,876 | –F1 | – | 191,531 | Indirect | |
| Jul 24, 2025 | Common Stock | CConversionAcquired | +26,993 | –F1 | – | 218,524 | Indirect | |
| Jul 24, 2025 | Common Stock | CConversionAcquired | +1,117,743 | –F1 | – | 1,117,743 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 24, 2025 | Common Stock | CConversionDisposed | −2,948,794 | $0.00 | $0 | 0 | Indirect | |
| Jul 24, 2025 | Common Stock | CConversionDisposed | −825,135 | $0.00 | $0 | 0 | Indirect | |
| Jul 24, 2025 | Common Stock | CConversionDisposed | −531,877 | $0.00 | $0 | 0 | Indirect | |
| Jul 24, 2025 | Common Stock | CConversionDisposed | −149,655 | $0.00 | $0 | 0 | Indirect | |
| Jul 24, 2025 | Common Stock | CConversionDisposed | −41,876 | $0.00 | $0 | 0 | Indirect | |
| Jul 24, 2025 | Common Stock | CConversionDisposed | −26,993 | $0.00 | $0 | 0 | Indirect | |
| Jul 24, 2025 | Common Stock | CConversionDisposed | −1,117,743 | $0.00 | $0 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the "Reverse Split"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date.
Referenced by the price of 7 transactions in Table I.